Michael L Bittner1,2, Rosana Lopes1, Jianping Hua1, Chao Sima1, Aniruddha Datta1, Heather Wilson-Robles3. 1. Center for Bioinformatics and Genomic Systems Engineering, Texas A&M Engineering Experiment Station, Texas A&M University, College Station, TX, United States of America. 2. Translational Genomics Research Institute, Phoenix, AZ, United States of America. 3. College of Veterinary Medicine, Texas A&M University, College Station, TX, United States of America.
Abstract
BACKGROUND: Several studies have highlighted both the extreme anticancer effects of Cryptotanshinone (CT), a Stat3 crippling component from Salvia miltiorrhiza, as well as other STAT3 inhibitors to fight cancer. METHODS: Data presented in this experiment incorporates 2 years of in vitro studies applying a comprehensive live-cell drug-screening analysis of human and canine cancer cells exposed to CT at 20 μM concentration, as well as to other drug combinations. As previously observed in other studies, dogs are natural cancer models, given to their similarity in cancer genetics, epidemiology and disease progression compared to humans. RESULTS: Results obtained from several types of human and canine cancer cells exposed to CT and varied drug combinations, verified CT efficacy at combating cancer by achieving an extremely high percentage of apoptosis within 24 hours of drug exposure. CONCLUSIONS: CT anticancer efficacy in various human and canine cancer cell lines denotes its ability to interact across different biological processes and cancer regulatory cell networks, driving inhibition of cancer cell survival.
BACKGROUND: Several studies have highlighted both the extreme anticancer effects of Cryptotanshinone (CT), a Stat3 crippling component from Salvia miltiorrhiza, as well as other STAT3 inhibitors to fight cancer. METHODS: Data presented in this experiment incorporates 2 years of in vitro studies applying a comprehensive live-cell drug-screening analysis of human and caninecancer cells exposed to CT at 20 μM concentration, as well as to other drug combinations. As previously observed in other studies, dogs are natural cancer models, given to their similarity in cancer genetics, epidemiology and disease progression compared to humans. RESULTS: Results obtained from several types of human and caninecancer cells exposed to CT and varied drug combinations, verified CT efficacy at combating cancer by achieving an extremely high percentage of apoptosis within 24 hours of drug exposure. CONCLUSIONS:CT anticancer efficacy in various human and caninecancer cell lines denotes its ability to interact across different biological processes and cancer regulatory cell networks, driving inhibition of cancer cell survival.
Authors: E S Saad; K M Milley; A A Al-Khan; J S Nimmo; B Bacci; M Tayebi; M J Day; S J Richardson; J A Danks Journal: J Comp Pathol Date: 2017-04-24 Impact factor: 1.311
Authors: K U Sorenmo; V M Kristiansen; M A Cofone; F S Shofer; A-M Breen; M Langeland; C M Mongil; A M Grondahl; J Teige; M H Goldschmidt Journal: Vet Comp Oncol Date: 2009-09 Impact factor: 2.613